surmount-1 trial tirzepatide non-diabetic weight loss for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled Tirzepatide for the treatment of
Description
Brand-name tirzepatide versus compounded: the real cost difference Brand-name tirzepatide comes in two FDA-approved forms

Both medications contain glucagon-like peptide-1 (GLP-1) receptor agonists

Yes, many patients switch from one to the other under medical supervision

17: Ard J, Lee CJ, Gudzune K, Addison B, Lingvay I, Cao D, Mast CJ, Stefanski A, Falcon B, Mojdami D

Our experienced medical team specializes in helping patients achieve sustainable weight loss using the latest, evidence-based treatments